Age (median) | 73 years |
(SD) | 3.7 years |
Gender | |
Female | 99 (47.8%) |
Male | 108 (52.2%) |
Surgery | |
No | 5 (2.5%) |
Biopsy | 69 (33.3%) |
Reduction | 96 (46.4%) |
Gross total resection | 37 (17.9%) |
Performance status WHO | |
0 | 3 (1.5%) |
I | 53 (25.6%) |
II | 65 (31.4%) |
III | 70 (33.8%) |
IV | 16 (7.7%) |
Radiotherapy | 158 (76.3%) |
> 50 Gy | 57 (27.5%) |
40-50 Gy | 33 (15.9%) |
≤ 40 Gy | 68 (32.8%) |
Temozolomide | 62 (30.0%) |